PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative net income growth while XRF.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.25%
Share change of 0.25% while XRF.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth of 0.00% while XRF.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while XRF.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-29.23%
Negative 10Y revenue/share CAGR while XRF.AX stands at 141.94%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
220.47%
5Y revenue/share CAGR above 1.5x XRF.AX's 43.01%. David Dodd would look for consistent product or market expansions fueling outperformance.
106.00%
3Y revenue/share CAGR above 1.5x XRF.AX's 50.54%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-243.98%
Negative 10Y OCF/share CAGR while XRF.AX stands at 17.02%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-423.72%
Negative 5Y OCF/share CAGR while XRF.AX is at 32.41%. Joel Greenblatt would question the firm’s operational model or cost structure.
-668.95%
Negative 3Y OCF/share CAGR while XRF.AX stands at 386.93%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
206.95%
Net income/share CAGR above 1.5x XRF.AX's 50.27% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
499.00%
Positive 5Y CAGR while XRF.AX is negative. John Neff might view this as a strong mid-term relative advantage.
60.24%
3Y net income/share CAGR above 1.5x XRF.AX's 16.93%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
1826.40%
5Y equity/share CAGR above 1.5x XRF.AX's 17.36%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
116.90%
3Y equity/share CAGR above 1.5x XRF.AX's 7.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.95%
AR growth of 7.95% while XRF.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.25%
We have a declining book value while XRF.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.